Baseline Clinical Profile of a “Normal Popu-lation” of HIV Exposed Sero-Negative (HESN) Partners May Impact HIV Biomedical Prevention Studies Negatively


The burden and viral diversity of HIV in Nigeria makes it suitable to evaluate biomedical prevention strategies including HIV vaccines. We document baseline clinical characteristics of a cohort of HIV Exposed Sero-Negative (HESN) partners to highlight background morbidities that might impact the interpretation of research findings especially in low income countries where “normal control” is based on physical appearance and self-reporting. We established a 2-year prospective cohort of HESN, and obtained, at baseline medical history, general physical examination findings and safety laboratory tests results. Among 534 participants with a mean age of 37 ± 9 years, the commonest symptoms were headache (25.5%) and fever (20%), which occurred more among females. Also, 13% reported a history of urethral/vaginal discharge and genital ulcer. High blood pressure (HBP) (i.e. blood pressure ≥ 140/90 mmhg) was a major abnormal examination finding, which occurred more among males (53.2% vs 26.2%, p < 0.01). More female participants had abnormal laboratory results with 31% having low hemoglobin concentration (<12 g/dl, p = 0.021); 30% with elevated alanine transaminase level (p = 0.019) and 28% with abnormal blood urea nitrogen level (p = 0.093). HBP and abnormal safety laboratory are significant findings among so called “normal population” that could affect interpretation of research findings of HIV biomedical prevention studies in Nigeria.

Share and Cite:

Datong, P. , Okpokoro, E. , Osawe, S. , Datiri, R. , Choji, G. , Okolo, F. , Abimiku, R. , Mamman, I. and Abimiku, A. (2015) Baseline Clinical Profile of a “Normal Popu-lation” of HIV Exposed Sero-Negative (HESN) Partners May Impact HIV Biomedical Prevention Studies Negatively. World Journal of AIDS, 5, 299-307. doi: 10.4236/wja.2015.54032.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] NACA (2011) Fact Sheet: Update on the HIV/AIDS Epidemic and Response in Nigeria. NACA, Boston.
[2] Cohen, M.S., et al. (2011) Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine, 365, 493-505.
[3] Vermund, S.H. (2013) Treatment as Prevention for HIV in China. Lancet, 382, 1159-1161.
[4] Reynolds, S.J., et al. (2011) HIV-1 Transmission among HIV-1 Discordant Couples before and after the Introduction of Antiretroviral Therapy. AIDS, 25, 473-477.
[5] Huachun, Z., et al. (2012) Condom Use in China: Prevalence, Policies, Issues and Barriers. Sexual Health, 9, 27-33.
[6] Baeten, J.M., et al. (2012) Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention among Heterosexual African Men and Women. New England Journal of Medicine, 367, 399-410.
[7] Rerks-Ngam, S., Pitisuttithum, P. and Nitayaphan, S. (2009) Vaccination with ALVAC and AIDSvax to Prevent HIV-1 Infection in Thailand. New England Journal of Medicine, 361, 2209-2220.
[8] Abimiku, A.G., et al. (1994) Subgroup G HIV Type 1 Isolates from Nigeria. Research and Human Retroviruses. Research and Human Retroviruses, 10, 1581-1583.
[9] WHO (2012) Guidance on Couples HIV Testing and Counselling Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples. Recommendations for a Public Health Approach, World Health Organization, Geneva.
[10] Omosa-Manyonyi, G.S., et al. (2011) Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya. PLoS ONE, 6, e14580.
[11] Altman, D. and Doré, C. (1990) Randomisation and Baseline Comparisons in Clinical Trials. The Lancet, 335, 149-153.
[12] Peduzzi, P., Henderson, W., Hartigan, P. and Lavori, P. (2002) Analysis of Randomized Controlled Trials. Epidemioloic Reviews, 24, 26-38.
[13] UT Health (2008) Clinical Trials Resource Center. Clinical Trials Glossary 2008.
[14] Miri-Dashe, T., Osawe, S., Tokdung, M., et al. (2014) Comprehensive Reference Ranges for Hematology and Clinical Chemistry Laboratory Parameters Derived from Normal Nigerian Adults. PLoS ONE, 9, e93919.
[15] Burgess, D.C., Gebski, V.J. and Keech, A.C. (2003) Baseline Data in Clinical Trials. Medical Journal of Australia, 179, 105-107.
[16] Akani, C.I., Erhabor, O., Opurum, H., et al. (2005) HIV Sero-Discordance among Nigerian Couples: Challenges and Controversies. Nigeria Medical Practitioner, 48, 62-66.
[17] Ruzagira, E., Wandiembe, S., Abaasa, A., et al. (2011) Prevalence and Incidence of HIV in a Rural Community-Based HIV Vaccine Preparedness Cohort in Masaka, Uganda. PLoS ONE, 6, e20684.
[18] Ige, K. and Nwachukwu, C. (2008) Health Care Seeking Behaviour among Market Traders in Ibarapa Central Local Government, Nigeria. The Internet Journal of Health, 9.
[19] Agbogidi, J. and Azodo, C. (2009) Experiences of the Elderly Utilizing Healthcare Services in Edo State. The Internet Journal of Geriatrics and Gerontology, 5.
[20] Gyoh, S. (2011) Doctors and the Truth. African Health, 34, 5.
[21] Sekoni, A.O., Odukoya, O.O., Onajole, A.T. and Odeyemi, K.A. (2013) Sexually Transmitted Infections: Prevalence, Knowledge and Treatment Practices among Female Sex Workers in a Cosmopolitan City in Nigeria. African Journal of Reproductive Health, 17, 94-102.
[22] Baltazar, R.M., et al. (2005) Prevalence of Sexually Transmitted Infections and Associated Risk Factors among Female Commercial Sex Workers in Cuantha, Morclos. Ginecología y Obstetricia de México, 73, 36-47.
[23] Balogun, M.O. and Owoaje, E.T. (2007) Work Conditions and Health Problems of Female Traders in Ibadan, Nigeria. African Journal of Medicine and Medical Sciences, 36, 57-63.
[24] Okechukwu, S.O., Okpechi, I., Chukwuonye, I.I., et al. (2012) Blood Pressure, Prevalence of Hypertension and Hypertension Related Complications in Nigerian Africans: A Review. World Journal of Cardiology, 4, 327-340.
[25] Pirraglia, P.A., Bishop, D., Herman, D.S., et al. (2005) Caregiver Burden and Depression among Informal Caregivers of HIV-Infected Individuals. Journal of General Internal Medicine, 20, 510-514.
[26] Player, M.S. and Peterson, L.E. (2011) Anxiety Disorders, Hypertension, and Cardiovascular Risk: A Review. International Journal of Psychiatry in Medicine, 41, 365-377.
[27] Damulak, O. and Damen, J. (2012) Diagnostic Outcome of Bone Marrow Aspiration in a New Centre in Nigeria. Global Advanced Journal of Medicine and Medical Sciences, 1, 166-171.
[28] Chen, S.C., Yeh, J.J., Chang, M.H., et al. (2010) Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents. PLoS ONE, 5, e13269.
[29] Song, H.R., Yun, K.E. and Park, H.S. (2008) Relation between Alanine Aminotransferase Concentrations and Visceral fat Accumulation among Nondiabetic Overweight Korean Women. The American Journal of Clinical Nutrition, 88, 16-21.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.